Pune: Serum Institute Gets Corona Vaccine Order From Government of India

Adar Poonawalla COVISHIELD
Share this News:

Harleen Kaur Grewal

Pune, January 11, 2021: The Serum Institute of India (SII) has received an order from the Government of India for the purchase of Coronavirus vaccine ‘Covishield’. The SII said that its vaccine would be available for Rs 200 per bottle. 

The Drug Controller General of India (DCGI) has approved the Covishield Vaccine of Serum Institute of India and the Covacixin of Bharat Biotech for emergency use in India. While giving the green signal for the use of the vaccine, DCGI Director VG Somani said that these vaccines are safe to use, and even though there may be mild side effects, there is nothing to fear.

The vaccination process is going to begin in the country from January 16. Preparations for the necessary logistics for the vaccination have started. On Friday, the second nationwide dry run of the Corona vaccine was conducted in all the 33 states and union territories of the country except UP and Haryana. This dry run is running in three sessions in a total of 736 districts. UP and Haryana have already had their dry runs.

According to the official statement, after a detailed review, it was decided that the Covid-19 vaccination campaign would start from 16 January 2021 in view of the upcoming festivals Lohri, Makar Sankranti, Pongal, Magh Bihu, etc. 

According to this, after the health workers and frontline workers, priority will be given to those above 50 years of age and those under 50 years of age who are already suffering from other diseases, which is about 27 crores. The government said the national regulator has given emergency use clearance or speedy approval to two vaccines (Covishield and Covaxine) which have been found to be capable of shielding the human body from the virus.

80% of Covishield vaccines to be flown out from Pune; transportation to start by Monday or Tuesday